Search Results
Search for other papers by Andrea Abate in
Google Scholar
PubMed
Search for other papers by Mariangela Tamburello in
Google Scholar
PubMed
Search for other papers by Elisa Rossini in
Google Scholar
PubMed
Search for other papers by Ram Manohar Basnet in
Google Scholar
PubMed
Search for other papers by Giovanni Ribaudo in
Google Scholar
PubMed
Search for other papers by Alessandra Gianoncelli in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany
Search for other papers by Constanze Hantel in
Google Scholar
PubMed
Search for other papers by Deborah Cosentini in
Google Scholar
PubMed
Search for other papers by Marta Laganà in
Google Scholar
PubMed
Search for other papers by Salvatore Grisanti in
Google Scholar
PubMed
Search for other papers by Guido Alberto Massimo Tiberio in
Google Scholar
PubMed
Search for other papers by Maurizio Memo in
Google Scholar
PubMed
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
Search for other papers by Sandra Sigala in
Google Scholar
PubMed
and metastasis formation, using both cell models and zebrafish embryos engrafted with ACC cells. Materials and methods Cell lines and culture conditions Both primary and metastatic ACC cell lines were used. The worldwide used primary ACC
Search for other papers by Annu Makker in
Google Scholar
PubMed
Search for other papers by Madhu Mati Goel in
Google Scholar
PubMed
risk tumors (stage IC–grade 3 or more advanced), which have invaded deep into the myometrium at diagnosis and progressively lead to local or extra pelvic metastasis with a 5-year survival ranging from 16 to 66% ( Ries et al . 2007 ). Several treatment
Search for other papers by Xi Wei in
Google Scholar
PubMed
Department of Radiotherapy and Oncology, the Second Affiliated Hospital of Soochow University, Suzhou, China
Search for other papers by Shang Cai in
Google Scholar
PubMed
Search for other papers by Rebecca J Boohaker in
Google Scholar
PubMed
Search for other papers by Joshua Fried in
Google Scholar
PubMed
Search for other papers by Ying Li in
Google Scholar
PubMed
Search for other papers by Linfei Hu in
Google Scholar
PubMed
Search for other papers by Yi Pan in
Google Scholar
PubMed
Search for other papers by Ruifen Cheng in
Google Scholar
PubMed
Search for other papers by Sheng Zhang in
Google Scholar
PubMed
Search for other papers by Ye Tian in
Google Scholar
PubMed
Search for other papers by Ming Gao in
Google Scholar
PubMed
Department of Molecular Radiation Oncology, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Search for other papers by Bo Xu in
Google Scholar
PubMed
, PIK3CA, PTEN and ALK genes in ATC ( Guerra et al . 2013 ). Because of the rapid progression and high invasiveness nature of ATC, at the time of diagnosis, most patients have already contracted extra-thyroid invasion and/or lymph metastasis, and many
Search for other papers by Noriko Kimura in
Google Scholar
PubMed
Search for other papers by Ryoichi Takayanagi in
Google Scholar
PubMed
Search for other papers by Nae Takizawa in
Google Scholar
PubMed
Search for other papers by Eiji Itagaki in
Google Scholar
PubMed
Search for other papers by Takayuki Katabami in
Google Scholar
PubMed
Search for other papers by Narihiko Kakoi in
Google Scholar
PubMed
Search for other papers by Hiromi Rakugi in
Google Scholar
PubMed
Search for other papers by Yukihiro Ikeda in
Google Scholar
PubMed
Search for other papers by Akiyo Tanabe in
Google Scholar
PubMed
Search for other papers by Takeshi Nigawara in
Google Scholar
PubMed
Search for other papers by Sadayoshi Ito in
Google Scholar
PubMed
Search for other papers by Itaru Kimura in
Google Scholar
PubMed
Search for other papers by Mitsuhide Naruse in
Google Scholar
PubMed
Search for other papers by The Phaeochromocytoma Study Group in Japan in
Google Scholar
PubMed
tumours have not been established and only the presence of metastasis is considered evidence of malignancy in the current WHO definition ( Thompson et al . 2004 ). Although most cases of PHEO/PGL are surgically curable, malignant PHEO/PGL are intractable
Search for other papers by Courtney A Dreyer in
Google Scholar
PubMed
Search for other papers by Kacey VanderVorst in
Google Scholar
PubMed
Search for other papers by Savannah Free in
Google Scholar
PubMed
Search for other papers by Ashley Rowson-Hodel in
Google Scholar
PubMed
Search for other papers by Kermit L Carraway III in
Google Scholar
PubMed
Introduction Breast cancer metastasis Despite significant advances in the detection and treatment of breast tumors over the last few decades, metastatic disease remains the primary cause of breast cancer-related deaths ( Weigelt et al
Search for other papers by Myriem Boufraqech in
Google Scholar
PubMed
Search for other papers by Lisa Zhang in
Google Scholar
PubMed
Search for other papers by Meenu Jain in
Google Scholar
PubMed
Search for other papers by Dhaval Patel in
Google Scholar
PubMed
Search for other papers by Ryan Ellis in
Google Scholar
PubMed
Search for other papers by Yin Xiong in
Google Scholar
PubMed
Search for other papers by Mei He in
Google Scholar
PubMed
Search for other papers by Naris Nilubol in
Google Scholar
PubMed
Search for other papers by Maria J Merino in
Google Scholar
PubMed
Search for other papers by Electron Kebebew in
Google Scholar
PubMed
metastasis, 90 000 8505C-Luc cells were injected into the tail vein of Cg- Prkdc scid Il2rg tm1Wjl /SzJ mice. The mice were intraperitoneally injected with 30 mg/ml of luciferin and imaged. The images were analyzed using IVIS Living Image software (Caliper
CNRS UMR7275, Valbonne, France
NEOGENEX CNRS International Associated Laboratory, Valbonne, France
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
Search for other papers by Enzo Lalli in
Google Scholar
PubMed
Search for other papers by Michaela Luconi in
Google Scholar
PubMed
tumors, but also, and most often, because of their specific hormonal secretion, which significantly contributes to their pathological burden. Malignant endocrine tumors, in addition, have the ability to produce distant metastases. Metastasis is the result
Search for other papers by Patricia V Elizalde in
Google Scholar
PubMed
Search for other papers by Rosalía I Cordo Russo in
Google Scholar
PubMed
Search for other papers by Maria F Chervo in
Google Scholar
PubMed
Search for other papers by Roxana Schillaci in
Google Scholar
PubMed
. 1989 , Ross et al . 2009 ). Decades of research since the discovery of MErbB-2 role as a potent inducer of BC growth in vitro and in preclinical models demonstrated that the ErbB-2-positive subtype is associated with high incidence of metastasis in
Search for other papers by Penelope D Ottewell in
Google Scholar
PubMed
Search for other papers by Ning Wang in
Google Scholar
PubMed
Search for other papers by Joshua Meek in
Google Scholar
PubMed
Search for other papers by C Anne Fowles in
Google Scholar
PubMed
Search for other papers by Peter I Croucher in
Google Scholar
PubMed
Search for other papers by Colby L Eaton in
Google Scholar
PubMed
Search for other papers by Ingunn Holen in
Google Scholar
PubMed
experimental models of bone metastasis use 5- to 6-week-old mice that have high bone remodelling rates, providing additional evidence that increased bone turnover promotes skeletal tumour growth. In keeping with this, administration of ZOL in young mice has
Search for other papers by Faith Nutter in
Google Scholar
PubMed
Search for other papers by Ingunn Holen in
Google Scholar
PubMed
Search for other papers by Hannah K Brown in
Google Scholar
PubMed
Search for other papers by Simon S Cross in
Google Scholar
PubMed
Search for other papers by C Alyson Evans in
Google Scholar
PubMed
Search for other papers by Matthew Walker in
Google Scholar
PubMed
Search for other papers by Robert E Coleman in
Google Scholar
PubMed
Search for other papers by Jules A Westbrook in
Google Scholar
PubMed
Search for other papers by Peter J Selby in
Google Scholar
PubMed
Academic Unit of Clinical Oncology, Academic Unit of Pathology, Leeds Institute of Molecular Medicine, Cancer Research UK (CR‐UK), and Yorkshire Cancer Research (YCR) Sheffield Cancer Research Centre
Search for other papers by Janet E Brown in
Google Scholar
PubMed
Search for other papers by Penelope D Ottewell in
Google Scholar
PubMed
Introduction As many as 75% of patients with advanced breast cancer will develop bone metastasis, and these have a poor prognosis with median survival rates of ∼2 years following initial diagnosis of bone involvement ( Major Cook et al . 2009